| Investor Type | Firm |
| Type of Fund | VC |
| Stages | Early Stage, Seed |
| Investing | Netherlands |
Thuja Capital is an early-stage venture capital fund that specializes in investments in the healthcare sector.
They aim to invest in healthcare innovation, from start-up to scale-up, predominantly within the Benelux region but also serving the broader European market. Their investment thesis revolves around finding and supporting entrepreneurial ventures that have the potential to make a lasting impact on patients and society.
They are particularly interested in paradigm-shifting ideas that address high unmet medical needs. Their approach includes treasure daring entrepreneurs, and they look to provide tranched investments to balance risk and return. Through their investments, they help to start, build, and accelerate ventures.
Thuja Capital builds sustainable value by supporting the development of novel therapies and healthcare solutions. Additionally, they place a strong emphasis on creating a positive impact and place importance on environmental, social, and governance (ESG) criteria in their investment decisions. They are an active supporter and member of the EU Life Sciences ESG Knowledge Project and have contributed to its 2025 questionnaire for investors.
Their team consists of Investment Management professionals as well as an Advisory Board, with partnerships and vacancies indicating a collaborative and growth-oriented mindset. Thuja Capital maintains a portfolio which they showcase on their website, sharing news and updates about their activities, investments, and the success of their portfolio companies.
Their firm is rooted in The Benelux but aims at serving the wider European community with their strategic investments.

